EUVIMEDEUVIMED entdecken
Crossref

Analysis of Denosumab by a Validated CZE Method and Determination of Sialic Acids by the RP–HPLC Method

Rafaela Ferreira Perobelli Dumoncel iD, Bruna Xavier, Clóvis Dervil Appratto Cardoso Júnior, Francielle Santos da Silva, Luís Gustavo Jung Motta, Thaís Neuhaus Cavalheiro, Sérgio Luiz Dalmora

Journal of Chromatographic Science · 2023

DOI: 10.1093/chromsci/bmac019 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Chromatographic Science, 2023. Verfasst von Rafaela Ferreira Perobelli Dumoncel und 6 weiteren Autor:innen. Beteiligte Einrichtung: Postgraduate Program in Pharmaceutical Sciences, Industrial Pharmacy Department, Federal University of Santa Maria, Santa Maria, RS 97105-900, Brazil. Hauptthemen laut MEDLINE: Sialic Acids, Denosumab. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 42 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A capillary zone electrophoresis (CZE) method was developed and validated to quantitate the monoclonal antibody denosumab (DmAb) and its charge variants in pharmaceutical products, demonstrating excellent precision, linearity and accuracy. Separations were obtained with migration times of 11.3 min for DmAb and the calibration curve was linear in the range of 0.95–20 mg/mL. The analytical comparability of seven batches of Prolia® showed mean differences of the estimated content/potencies of 1.87% lower, and 0.84 and 1.21% higher compared with the size-exclusion and reversed-phase liquid chromatography (SE–HPLC and RP–HPLC) methods and the osteoclast antiproliferative bioassay, respectively, with non-significant differences (P > 0.05). An RP–HPLC method with fluorescence detection (RP–HPLC–F), performed on a Kinetex® EVO C18 column (5 μm, 100 Å, 250 mm × 4.6 mm), was optimized to determine the levels of sialic acids of DmAb biomolecules, giving mean concentrations of 0.16 and 0.17 μg N-acetylneuraminic acid/mg DmAb for Prolia® and Xgeva® pharmaceutical products, respectively. The results demonstrated the capability of each one of the methods, and their use in combination constitutes a strategy to monitor instability, thereby assuring the quality and the batch-to-batch consistency of the biotechnology-derived medicine.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Sialic AcidsDenosumabChromatography, High Pressure LiquidElectrophoresis, CapillaryPharmaceutical Preparations

Substanzen

Sialic AcidsDenosumabPharmaceutical Preparations

Autor:innen und Institutionen

  • Postgraduate Program in Pharmaceutical Sciences, Industrial Pharmacy Department, Federal University of Santa Maria, Santa Maria, RS 97105-900, Brazil.
  • Industrial Pharmacy Department, Federal University of Santa Maria, Santa Maria, RS 97105-900, Brazil.

ORCID-Profile: Rafaela Ferreira Perobelli Dumoncel

Zitieren

APA

Dumoncel, R. F. P., Xavier, B., Cardoso Júnior, C. D. A., da Silva, F. S., Motta, L. G. J., Cavalheiro, T. N., & Dalmora, S. L. (2023). Analysis of Denosumab by a Validated CZE Method and Determination of Sialic Acids by the RP–HPLC Method. Journal of Chromatographic Science. https://doi.org/10.1093/chromsci/bmac019

Vancouver

Dumoncel RFP, Xavier B, Cardoso Júnior CDA, da Silva FS, Motta LGJ, Cavalheiro TN, et al. Analysis of Denosumab by a Validated CZE Method and Determination of Sialic Acids by the RP–HPLC Method. Journal of Chromatographic Science. 2023. doi:10.1093/chromsci/bmac019

BibTeX
@article{Dumoncel2023,
  author = {Dumoncel, Rafaela Ferreira Perobelli and Xavier, Bruna and Cardoso Júnior, Clóvis Dervil Appratto and da Silva, Francielle Santos and Motta, Luís Gustavo Jung and Cavalheiro, Thaís Neuhaus and Dalmora, Sérgio Luiz},
  title = {Analysis of Denosumab by a Validated CZE Method and Determination of Sialic Acids by the RP–HPLC Method},
  journal = {Journal of Chromatographic Science},
  year = {2023},
  doi = {10.1093/chromsci/bmac019}
}
Kostenlos starten →